HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin Funk Selected Research

Cisplatin (Platino)

1/2022Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin Funk Research Topics

Disease

5Insulin Resistance
10/2022 - 01/2019
3Neoplasms (Cancer)
01/2022 - 09/2019
2Melanoma (Melanoma, Malignant)
01/2022 - 09/2019
2Body Weight (Weight, Body)
01/2020 - 07/2015
1Laron Syndrome (Syndrome, Laron)
01/2023
1Infections
01/2023
1Chagas Disease (American Trypanosomiasis)
01/2023
1Frailty
10/2022
1Thrombosis (Thrombus)
01/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020
1Fibrosis (Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

4Insulin-Like Growth Factor I (IGF-1)IBA
01/2023 - 01/2019
3Insulin (Novolin)FDA Link
01/2023 - 01/2020
3Somatotropin Receptors (Growth Hormone Receptor)IBA
10/2022 - 12/2021
2Growth Hormone (Somatotropin)IBA
01/2023 - 09/2019
2AdiponectinIBA
10/2022 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
10/2022 - 07/2015
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2022 - 09/2019
1AdipokinesIBA
10/2022
1C-PeptideIBA
10/2022
1CytokinesIBA
10/2022
1ResistinIBA
10/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1CASINIBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2021
1Prolactin Receptors (Prolactin Receptor)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
09/2019
1Triglycerides (Triacylglycerol)IBA
01/2019

Therapy/Procedure

3Therapeutics
01/2022 - 09/2019